Northern Trust Corp Jaguar Health, Inc. Transaction History

Northern Trust Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.17 - $765.0 $2,700 - $12.2 Million	15,883 Added 21.26%	90,582 $14,000
Q4 2021 Feb 08, 2022	SELL	$1.03 - $2.48 $35,298 - $84,989	-34,270 Reduced 31.45%	74,699 $78,000
Q3 2021 Nov 15, 2021	BUY	$2.14 - $4.95 $233,193 - $539,396	108,969 New	108,969 $247,000

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $122M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.